4016108 Public Oversight Roundtable Notice on "Impacts of Pharmaceutical Marketing on Healthcare Services in the District of Columbia: Focus on Use of Antipsychotics in Children"

Committee on Health

Notice of Public Oversight Roundtable

 

1350 Pennsylvania Avenue, NW, Washington, D.C. 20004

 

 

COUNCILMEMBER DAVID A. CATANIA, CHAIRPERSON

COMMITTEE ON HEALTH

 

Announces a Public Oversight Roundtable

 

On

 

Impacts of Pharmaceutical Marketing on Healthcare Services in the District of Columbia:

Focus on Use of Antipsychotics in Children

 

On

 

Tuesday, November 13, 2012

10:00 AM

 

Room 500

1350 Pennsylvania Avenue, NW

Washington, D.C. 20004

 

 

Councilmember David A. Catania, Chairperson of the Committee on Health, announces  an Oversight Roundtable to review the Department of Health’s Health Regulation and Licensing Administration report entitled ”Impacts of Pharmaceutical Marketing on Healthcare Services in the District of Columbia: Focus on Use of Antipsychotics in Children.”  The roundtable will be held on Tuesday, November 13, 2012 at 10:00 AM in Room 500 of the John A. Wilson Building, 1350 Pennsylvania Avenue, NW. 

 

Only invited witnesses will be permitted to provide oral statements.  Members of the public may submit written testimony which will be made part of the official record.  Copies of written statements should be submitted to the Committee on Health no later than 5:30 PM on Tuesday, November 20, 2012.